Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- Metagenics and BioMeridian Form Partnership
Metagenics Inc. and BioMeridian Corp. have announced the formation of a partnership to provide health practitioners with a newly developed software tool named "BioRep(TM)", designed to assist practitioners to assess patients' health and recommend an optimal supplementation protocol.
- Metagenics and BioMeridian Form Partnership
Metagenics Inc. and BioMeridian Corp. have announced the formation of a partnership to provide health practitioners with a newly developed software tool named "BioRep(TM)", designed to assist practitioners to assess patients' health and recommend an optimal supplementation protocol.
- Metagenics and BioMeridian Form Partnership
Metagenics Inc. and BioMeridian Corp. have announced the formation of a partnership to provide health practitioners with a newly developed software tool named "BioRep(TM)", designed to assist practitioners to assess patients' health and recommend an optimal supplementation protocol.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- The UGR Patents A Process To Obtain A Protein As A Natural Colorant
A research team of the Universities of Granada have devised a process to obtain a natural colorant from the micro-algae Porphyridium cruentum. According to the researchers, the species contains a protein known as ficoerithrin which gives the micro-algae a reddish colour, and the researchers designed a process to obtain the B-ficoeritrina protein from this microalgae, which is characterized by its “high performance”, about 66%.
- The UGR Patents A Process To Obtain A Protein As A Natural Colorant
A research team of the Universities of Granada have devised a process to obtain a natural colorant from the micro-algae Porphyridium cruentum. According to the researchers, the species contains a protein known as ficoerithrin which gives the micro-algae a reddish colour, and the researchers designed a process to obtain the B-ficoeritrina protein from this microalgae, which is characterized by its “high performance”, about 66%.
- The UGR Patents A Process To Obtain A Protein As A Natural Colorant
A research team of the Universities of Granada have devised a process to obtain a natural colorant from the micro-algae Porphyridium cruentum. According to the researchers, the species contains a protein known as ficoerithrin which gives the micro-algae a reddish colour, and the researchers designed a process to obtain the B-ficoeritrina protein from this microalgae, which is characterized by its “high performance”, about 66%.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Global Pharmatech Receives Two New Patents
Company announces that the State Intellectual Property Office of the P. R. China has recently granted new patents to two drug candidates, Shenxiangsuhe Pills (patent number: ZL200410010947.7) and Xinshu Pills (patent number: ZL200410011088.3) to Natural Pharmatech (Jilin), a wholly owned subsidiary of Global Pharmatech, Inc.
- Global Pharmatech Receives Two New Patents
Company announces that the State Intellectual Property Office of the P. R. China has recently granted new patents to two drug candidates, Shenxiangsuhe Pills (patent number: ZL200410010947.7) and Xinshu Pills (patent number: ZL200410011088.3) to Natural Pharmatech (Jilin), a wholly owned subsidiary of Global Pharmatech, Inc.
- Global Pharmatech Receives Two New Patents
Company announces that the State Intellectual Property Office of the P. R. China has recently granted new patents to two drug candidates, Shenxiangsuhe Pills (patent number: ZL200410010947.7) and Xinshu Pills (patent number: ZL200410011088.3) to Natural Pharmatech (Jilin), a wholly owned subsidiary of Global Pharmatech, Inc.
- SemBioSys reacquires rights to DermaSphere(R) Oleosome Technology
Company announcec the conclusion of its relationship with Lonza Inc. for the manufacture and sale of its DermaSphere(R) Oleosome Technology.
- SemBioSys reacquires rights to DermaSphere(R) Oleosome Technology
Company announcec the conclusion of its relationship with Lonza Inc. for the manufacture and sale of its DermaSphere(R) Oleosome Technology.
- SemBioSys reacquires rights to DermaSphere(R) Oleosome Technology
Company announcec the conclusion of its relationship with Lonza Inc. for the manufacture and sale of its DermaSphere(R) Oleosome Technology.
- SemBioSys reacquires rights to DermaSphere(R) Oleosome Technology
Company announcec the conclusion of its relationship with Lonza Inc. for the manufacture and sale of its DermaSphere(R) Oleosome Technology.
- New Zealand: Science backs new health product technology
A unique micro encapsulation process has been developed by Auckland-based Drapac enabling friendly bacteria to remain active and fully effective at room temperature, giving them greater shelf life. According to the company, ingredients such as milk extracts, kiwifruit and other natural products are targets to encapsulate with its probiotic bacteria.
- New Zealand: Science backs new health product technology
A unique micro encapsulation process has been developed by Auckland-based Drapac enabling friendly bacteria to remain active and fully effective at room temperature, giving them greater shelf life. According to the company, ingredients such as milk extracts, kiwifruit and other natural products are targets to encapsulate with its probiotic bacteria.
- New Zealand: Science backs new health product technology
A unique micro encapsulation process has been developed by Auckland-based Drapac enabling friendly bacteria to remain active and fully effective at room temperature, giving them greater shelf life. According to the company, ingredients such as milk extracts, kiwifruit and other natural products are targets to encapsulate with its probiotic bacteria.
- New Zealand: Science backs new health product technology
A unique micro encapsulation process has been developed by Auckland-based Drapac enabling friendly bacteria to remain active and fully effective at room temperature, giving them greater shelf life. According to the company, ingredients such as milk extracts, kiwifruit and other natural products are targets to encapsulate with its probiotic bacteria.
- New Zealand: Science backs new health product technology
A unique micro encapsulation process has been developed by Auckland-based Drapac enabling friendly bacteria to remain active and fully effective at room temperature, giving them greater shelf life. According to the company, ingredients such as milk extracts, kiwifruit and other natural products are targets to encapsulate with its probiotic bacteria.
- New European ARA Infant Formula Patent Strengthens Martek's Intellectual Property Position
Company announces that the European Patent Office (EPO) has granted another patent to Martek for ARA (arachidonic acid) oil made from Martek's microbial source for use in infant formula. This patent covers infant formula supplemented with ARA from Mortierella alpina microorganisms and methods for producing infant formulas with ARA from Mortierella alpina.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
TAMPA, Fla. & MATAWAN, N.J., Sep 13, 2006 (BUSINESS WIRE) -- UTEK Corporation (UTK) (LSE-AIM:UTK), a specialty finance company focused on technology transfer, and MM2 Group, Inc. (MMGP) , a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement.
Mark Meller, Chief Executive Officer of MM2 Group, Inc. said, "We are enthusiastic about forming a strategic alliance with UTEK Corporation which we believe will enable us to identify synergistic technology acquisition opportunities. We are especially excited given UTEK's expertise in nutraceuticals and supplements, which fits well with our current business plans."
"UTEK looks forward to working with MM2 Group, Inc. to identify and potentially transfer proprietary technologies that will be synergistic with its core business," said Doug Schaedler, Chief Operating Officer of UTEK Corporation. Through its strategic alliance agreements, UTEK assists companies in enhancing their new product pipeline with the acquisition of proprietary intellectual capital from universities and laboratory research centers. Strategic alliance agreements are generally cancelable by either party with thirty days advance written notice.
About MM2 Group, Inc. MM2 Group, Inc. is a financial consulting group, providing both publicly-traded and private companies with short-term, mid-term, and long-term capital. MM2 Group, Inc. is also focused on an aggressive acquisition strategy and is supported by our solid working relationships with some of the largest and most respected investment funds, venture capital firms, and hedge funds in the world. The Company has recently announced its intention to acquire Genotec Nutritionals, Inc., a leading nutraceutical manufacturing and distribution company. For more information about MM2 Group, Inc., please visit its website at http://mm2group.net.
About UTEK Corporation UTEK(R) is a specialty finance company focused on technology transfer. UTEK's services enable companies to acquire innovative technologies from universities and research laboratories worldwide. UTEK facilitates the identification and acquisition of external technologies for clients in exchange for their equity securities. This unique process is called U2B(R). In addition, UTEK offers companies the tools to search, analyze and manage university intellectual properties. UTEK is a business development company with operations in the United States, United Kingdom and Israel. For more information about UTEK, please visit its website at http://www.utekcorp.com .
Forward-Looking Statements Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words, such as UTEK or MM2 Group, Inc. "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe UTEK's or MM2 Group, Inc.'s future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of UTEK or MM2 Group, Inc., as appropriate, and the valuation of UTEK's investment portfolio, which could cause actual results to differ materially from those currently anticipated. Although UTEK and MM2 Group, Inc. believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, they cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. These forward-looking statements are only made as of the date of this press release and both UTEK and MM2 Group, Inc. do not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
UTEK's operating results could fluctuate significantly due to a number of factors. These factors include the small number of transactions that are completed each quarter, the value of individual transactions, the timing of the recognition and the magnitude of unrealized gains and losses, UTEK's dependence on the performance of companies in its portfolio, the possibility that advances in technology could render the technologies it has transferred obsolete, the loss of technology licenses by companies in its portfolio, the degree to which it encounters competition in its markets, the volatility of the stock market and the volatility of the valuations of the companies it has invested in as it relates to its realized and unrealized gains and losses, the concentration of investments in a small number of companies, as well as other general economic conditions. As a result of these and other factors, current results may not be indicative of UTEK's future performance. For more information on UTEK and for a more complete discussion of the risks pertaining to an investment in UTEK, please refer to UTEK's filings with the Securities and Exchange Commission. |